v3.25.1
PROVISION FOR EMPLOYEE BENEFITS
12 Months Ended
Dec. 31, 2024
PROVISION FOR EMPLOYEE BENEFITS  
PROVISION FOR EMPLOYEE BENEFITS

NOTE 13 PROVISION FOR EMPLOYEE BENEFITS

Short term provision for employee benefits

    

2024

    

2023

Provision for personnel bonus

405,791

290,998

Provision for unused vacation

 

116,333

 

126,848

 

522,124

 

417,846

The movements in provisions for personnel bonus and unused vacation for the years ended 31 December 2024 and 2023 are as follows:

    

    

Current

    

Paid

    

    

1  January

year

during

Monetary

31 December

2024

charge

the year

gain

2024

Personnel bonus

 

290,998

 

459,019

 

(272,718)

(71,508)

 

405,791

Unused vacation

 

126,848

 

41,712

 

(8,861)

(43,366)

 

116,333

 

417,846

 

500,731

 

(281,579)

(114,874)

 

522,124

    

    

Current

    

Paid

    

    

1 January

year

during

Monetary

31 December

2023

charge

the year

gain

2023

Personnel bonus

 

285,432

 

372,066

 

(253,671)

(112,829)

 

290,998

Unused vacation

 

85,851

 

113,671

 

(16,222)

(56,452)

 

126,848

 

371,283

 

485,737

 

(269,893)

(169,281)

 

417,846

Long term provision for employee benefits

    

2024

    

2023

Provision for post-employment benefits

    

153,780

    

150,563

 

153,780

 

150,563

Post-employment benefits

Under the Turkish Labour Law, the Company is required to pay post-employment benefits to each employee who has completed one year of service and whose employment is terminated without due cause, or who is called up for military service, dies or retires after completing 25 years of service (20 years for women) and achieves the retirement age (58 for women and 60 for men). The maximum amount payable equivalent to one month’s salary for each year of service limited to a maximum of TRY41,828.42 for each year of service at 31 December 2024 (2023: TRY23,489.83 (historical amount)).

Post-employment benefit liability is not funded and there is no legal funding requirement.

NOTE 13 PROVISION FOR EMPLOYEE BENEFITS (Continued)

Long term provision for employee benefits (Continued)

IAS 19 “Employee Benefits” requires actuarial valuation methods to be developed to estimate the Group’s obligation under the defined benefit plans. Actuarial gain/(loss) is accounted under the “Actuarial gain/(loss) on the equity”. The following actuarial assumptions are used in the calculation of the total liability:

    

2024

    

2023

Discount rate (%)

 

3.00

 

2.46

Probability of retirement (%)

 

74.65

 

74.63

The principal assumption is that the maximum liability for each year of service will increase in line with inflation. Thus, the discount rate applied represents the expected real rate after adjusting for the anticipated effects of future inflation. The retirement pay provision ceiling TRY46,655.43 (historical amount) which is effective from 1 January 2025, is taken into consideration in the calculation of provision for employment termination benefits (31 December 2023: TRY35,058.58 (historical amount) effective from 1 January 2024).

The movements in the provision for the post-employment benefit for the years ended 31 December 2024 and 2023 are as follows:

    

2024

    

2023

At 1 January

 

150,563

 

39,151

Charge for the year

 

48,252

 

65,236

Interest cost

 

21,504

 

17,990

Actuarial losses

 

22,071

 

108,441

Payments during the year

 

(35,363)

 

(29,923)

Monetary gain

(53,247)

(50,332)

At 31 December

 

153,780

 

150,563

Share-based payments

On 25 March 2021, the Group approved a new share-based payment plan to some of its key management personnel which modified the previously created share-based payment plans. Additionally, on 31 July 2021, the Group decided to grant to some of its other executives, a share-based plan with similar terms offered to its executives. The share-based payment plans consist of a cash settlement clause (20% of the total share-based payment award) in the event that an initial public offering (“IPO”) takes place until 2021 year-end and at least 20% of the Company’s shares are sold in the IPO (non-market performance condition). Both the cash and equity settlement (which depend on the valuation of the shares during the IPO) take place only in case the valuation of the Company’s shares in the IPO achieves a certain threshold (market performance condition). The same plan has an equity settlement clause where the executives will be entitled to receive Company’s shares based on the value of the shares in the IPO (20% of the share-based payment award for each year starting from 18 months after the IPO for the next 3 years). Shares will be delivered to executives in the condition that they continue working for the Company in the respective payment dates (service condition). Remaining 20% of the share-based payment plan will be delivered on the above same dates to executives in terms of Company’s shares based on Company’s meeting at least 90% of its business plans as of respective years (non-market performance condition) and depending on their performance in the relevant period as determined by the Board of Directors.

NOTE 13 - PROVISION FOR EMPLOYEE BENEFITS (Continued)

Long term provision for employee benefits (Continued)

Share-based payments (Continued)

On 24 April 2023, the Board of Directors adopted revisions to Group’s share based payment plan dated 24 March 2021 for key executives, directors, managers, officers, employees and consultants who contribute to the Group’s performance. The revisions made to the share based payment plan consisted of allocating the unused portion of the share amount of the First Period into two newly created periods, namely, the Fourth Period and the Fifth Period, without changing the eligibility criteria of the share based payment plan and without affecting the vested rights of the individuals that have been covered under the First, Second and Third Period based on their individual agreement signed prior to the date of the revision.

The equity settled payments are triggered upon meeting certain “vesting” and “performance target” conditions which are evaluated separately. In the plan approved on 25 March 2021, service-based awards vest in three tranches until 31 January 2025. In the plan approved on 24 April 2023, service-based awards vest in three tranches until 31 January 2027. The cost of equity settled plans granted on grant date is allocated over the expected vesting period against equity on a pro rata basis. The cost of equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model. Fair value calculation prior to the realization of IPO was performed using a combination of income approach and market approach. For equity-settled plans granted after the realization of IPO, fair value of shares traded in NASDAQ at grant date was used.

The following table summarizes the Group’s granted share units:

    

    

Weighted average

Number of units

grant date fair value

Outstanding as of 31 December 2023

2,835,380

324.74

Units granted

 

2,367,881

 

98.34

Units vested

 

(2,632,362)

 

68.36

Units forfeited (vested)

(83,945)

44.17

Outstanding as of 31 December 2024

 

2,486,954

 

442.59

 

 

Weighted average

    

Number of units

    

grant date fair value

Outstanding as of 31 December 2022

 

1,766,235

 

294.20

Units granted

 

2,726,388

 

56.39

Units vested

 

(1,631,405)

 

94.17

Units forfeited (not yet vested) (*)

 

(25,838)

 

32.34

Outstanding as of 31 December 2023

 

2,835,380

 

324.74

(*)

Forfeited but not yet vested units consist of units granted on 9 December 2022 and forfeited before vesting period.

NOTE 13 - PROVISION FOR EMPLOYEE BENEFITS (Continued)

Long term provision for employee benefits (Continued)

Share-based payments (Continued)

During 2024, the fair value of granted share units that vested is TRY179,945 thousand (2023: TRY153,622 thousand) included in “other capital reserves” in the statement of changes in equity and in payroll and outsource staff expenses in the statement of comprehensive income/(loss). Scheduled vesting of outstanding restricted stock units as of 31 December 2024 and 2023 is as follows:

    

2024

    

2023

2024

 

1,639,156

2025

1,792,403

857,167

2026

653,423

319,632

2027

 

41,128

19,425

Total

 

2,486,954

2,835,380